MAM
LG launches XPC series; ad-spends to jump
BANGALORE: LG Electronics India Ltd. (LGEIL) has launched its XPC series of desktops in the price range of Rs.35,000 to Rs.50,000.
XPC is a PC cum entertainment system, allowing live recording of TV programs added with provision for pause, rewind, edit and maintain video library for later viewing.
The product comes with the latest Microsoft Media Center Edition (MCE) Operating System, designed to provide a true blend of computing and entertainment. In combination with MCE OS and high end processors like Intel’s LGA775 / AMD’s Athlon64, XPC offers leading edge features like high speed processing, access to media storage with remote, Personal Video Recording and multi-function.
‘Perform in style’ is LG’s new catch phrase for their XPO range.
A company source says that approximately Rs 220 million would be pumped in for ad-campaigns from the PC and peripherals wing this year as against the Rs 120-130 million invested last year. TV commercials focusing LG as a PC company, with an emphasis on laptops and notebooks have been planned. LG intends to pour in more money to build up a brand image. The new commercials are likely to hit the tube by the end of this month.
Creative and media for LG’s Pc products are being handled by McCann-Erickson, while Lintas are involved in brand building for TVC’s.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
